Insider Transactions in Q2 2024 at Soleno Therapeutics Inc (SLNO)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2024
|
Matthew Pauls |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+50.0%
|
-
|
|
Jun 06
2024
|
Andrew Sinclair |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+50.0%
|
-
|
|
Jun 06
2024
|
Birgitte Volck |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+32.43%
|
-
|
|
Jun 06
2024
|
William G Harris |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+29.68%
|
-
|
|
Jun 06
2024
|
Ernest Mario |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+3.26%
|
-
|
|
May 21
2024
|
Ernest Mario |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
62,000
+24.94%
|
$248,000
$4.5 P/Share
|
|
Apr 30
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
351,242
-4.58%
|
$15,805,890
$45.13 P/Share
|
|
Apr 29
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
750,000
-8.91%
|
$35,250,000
$47.8 P/Share
|
|
Apr 01
2024
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
2,218
-4.42%
|
$90,938
$41.39 P/Share
|
|
Apr 01
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
18,980
-5.68%
|
$778,180
$41.39 P/Share
|
|
Apr 01
2024
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
2,218
-2.4%
|
$90,938
$41.39 P/Share
|
|
Apr 01
2024
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,175
-3.87%
|
$212,175
$41.39 P/Share
|